Varitect CP (Varicella zoster Immunoglobulin human Vials) 125IE/5ml

Varitect CP is a varicella zoster immunoglobulin human solution in vials (125IE/5ml) used for passive immunization. Store at 2-8°C to maintain potency. This product is designed for individuals requiring protection against varicella zoster virus exposure.

Strength

125IE/5ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Biotest

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Varitect CP is used for passive immunization against varicella zoster virus. It provides temporary protection for individuals without immunity who have been exposed to the virus. This includes high-risk patients such as immunocompromised individuals or newborns of mothers with varicella around delivery.

Side Effects

As a human immunoglobulin, Varitect CP works by providing preformed antibodies to help the body fight off varicella zoster virus. It may reduce the severity of infection if administered promptly after exposure. Users may notice general improvement in symptoms if infection occurs.

Precautions & Warnings

Store Varitect CP between 2-8°C and avoid freezing. Do not use if the solution is discolored or contains particles. Consult a healthcare provider before use if you have a history of severe allergic reactions to immunoglobulins. Keep out of reach of children.

Avoid Interactions

Varitect CP may interact with live virus vaccines, potentially reducing their effectiveness. Avoid receiving live vaccines for at least 3 months after administration. Immunosuppressive therapies may reduce the effectiveness of Varitect CP. Always inform your healthcare provider about all medications being taken.

Frequently Asked Questions

It is used for passive immunization against varicella zoster virus exposure in high-risk individuals.

Store at 2-8°C and avoid freezing; do not use if the solution is discolored or contains particles.

Consult a healthcare provider to assess risks and benefits before use during pregnancy.

Common effects may include injection site reactions or mild allergic responses.

It should be administered as soon as possible after exposure for optimal effectiveness.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.